Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 156
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Is It Worth It? What Colorado’s Early Experience With Regulated Psychedelic Care Has the Field Asking, and What To Do About It
Compass Says NDA Will Be Filed Within Two Weeks, Declines to Comment on Usona
Podcast: Usona Files Psilocybin Application, We Review 610 Comments Submitted to FDA, and FDA Approves NRx’s Generic Ketamine
Usona Files Psilocybin for Depression NDA as Race With Compass Tightens
Jackie Tileston: Nondual Mysticism, 5-MeO-DMT, and the Trouble with Psychedelic Art
Racing Beyond Racemic: A Look at Ketamine Drug Development Ahead of...
Surprising Results: Psilocybin Trial for Depression Alleviates Chronic Pain
PT373 – Integrative Psychiatry & The Safety of At-Home Ketamine
Interview | Elliot Marseille, Global Initiative for Psychedelic Science Economics...
Psychedelics Weekly – Wonderland Controversy and Colorado Proposition 122
Psychedelics Weekly – Wonderland Controversy and Colorado Proposition 122
Psychedelic Bulletin #123: Colorado Psilocybin Therapy Prop Passes While Swathes of...
PT372 – The Heroic Hearts Project: Veterans and The Impact of...
FILAMENT HEALTH ANNOUNCES THIRD QUARTER 2022 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS
Healthline – Mental Health Breakthrough: The Therapeutic Benefits of Psychedelics
Load more
